News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
278 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (15)
2 (202)
3 (277)
4 (157)
5 (4)
6 (20)
7 (338)
8 (259)
9 (169)
10 (136)
11 (69)
12 (2)
13 (5)
14 (180)
15 (278)
16 (196)
17 (214)
18 (92)
19 (3)
20 (8)
21 (80)
22 (246)
23 (224)
24 (214)
25 (91)
26 (1)
27 (5)
28 (191)
29 (236)
30 (198)
31 (235)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Auditdata A/S appoints new leadership
Auditdata announces that founder and CEO of Auditdata will step down and incoming CEO Kurt Bager will take over at the end of January 2019
January 15, 2019
·
2 min read
Job Trends
Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated
Study underscores importance of sharing risks with patients considering lung cancer screening
January 15, 2019
·
5 min read
Drug Development
Merck’s Keytruda Cuts Death Risk by 31% in Esophageal Cancer
Merck’s Keytruda just keeps on proving its value to the company and patients. The company released data from KEYNOTE-181, a Phase III trial of Keytruda as a monotherapy for the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma.
January 15, 2019
·
3 min read
·
Mark Terry
FDA
Aimmune’s Peanut Allergy Treatment Delayed as Government Shutdown Continues
The partial government shutdown has entered day 24 and the pharma and medtech industry is beginning to feel the impact even more, particularly as the U.S. Food and Drug Administration grows more incapable of reviewing some medications for approval.
January 15, 2019
·
2 min read
·
Alex Keown
Business
Pfizer Cuts 150 Jobs, Along With Broader R&D Reconfigurations
After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development. The bottom line is the company is ending five preclinical programs in its biosimilar area and cutting 150 positions.
January 15, 2019
·
3 min read
·
Mark Terry
Policy
Wave Life Sciences Enters FDA’s Clinical Trial Pilot Program to Develop DMD Drug
Wave Life Sciences is working to get its nucleic acid treatment, suvodirsen, for Duchenne muscular dystrophy (DMD) approved. DMD is a rare muscle-wasting disease that affects mostly boys, about 15,000 in the U.S.
January 15, 2019
·
3 min read
·
Mark Terry
Biotech Beach
Beyond Limits Forms AI Healthcare Advisory Board to Inspire a Cognitive Leap in Healthcare
Beyond Limits, a leading artificial intelligence engineering company, has announced the formation of a healthcare advisory board composed of prominent physicians and healthcare executives from world-renowned medical clinics and companies.
January 15, 2019
·
4 min read
Drug Development
Exclusive Interview: VistaGen CEO Is Passionate About Developing New Treatments for Depression
Developing treatments to help those struggling with depression, a disorder that can lead to suicide, has become a mission for Shawn Singh, CEO of VistaGen, and his colleagues.
January 15, 2019
·
3 min read
·
Alex Keown
Endoscopic thyroidectomy seen as minimally invasive and less complicated treatment for thyroid disorders
Transoral approach aims to achieve scar-free surgery with minimal dissection
January 15, 2019
·
1 min read
CARMAT presents positive interim results of the first part of its PIVOTAL study
CARMAT today announced an update on its clinical progress and recent developments, as well as its cash position at December 31, 2018.
January 15, 2019
·
8 min read
1 of 28
Next